Dolphin Pharmacy Instruments Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -12.23%
- Profit Growth 947.25%
- Ebitda 947.25%
- Net Worth 116.25%
- Total Assets 38.20%
About Dolphin Pharmacy Instruments
Dolphin Pharmacy Instruments Private Limited (DPIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 08 April 2016 (Eight years and nine months 24 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmesh Shah and Dipesh Shah serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24110MH2016PTC279917
- Company No.
279917
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Dolphin Pharmacy Instruments Private Limited offer?
Dolphin Pharmacy Instruments Private Limited offers a wide range of products and services, including Medical Laboratory Instruments, Pathology Lab Equipments, Analyzers & Analytical Instruments, Spectrophotometer, Form Fill & Seal Machines, Pharmaceutical Packaging Machines, Laboratory & Lab Equipment, Laboratory Chamber, Filters & Filtration Systems, Filters.
Who are the key members and board of directors at Dolphin Pharmacy Instruments?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmesh Shah  | Director | 08-Apr-2016 | Current |
| Dipesh Shah | Director | 08-Apr-2016 | Current |
Financial Performance of Dolphin Pharmacy Instruments.
Dolphin Pharmacy Instruments Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 12.23% decrease. The company also saw a substantial improvement in profitability, with a 947.25% increase in profit. The company's net worth Soared by an impressive increase of 116.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dolphin Pharmacy Instruments?
In 2021, Dolphin Pharmacy Instruments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Volantes LlpDipesh Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dolphin Pharmacy Instruments?
Unlock and access historical data on people associated with Dolphin Pharmacy Instruments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dolphin Pharmacy Instruments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dolphin Pharmacy Instruments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.